Composition
- Active ingredients
- DEFERASIROX 90MG
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- DEFERASIROX 250MG · Tablet, for suspensionANDA208882-002 · Discontinued
- DEFERASIROX 500MG · Tablet, for suspensionANDA208882-003 · Discontinued
- DEFERASIROX 125MG · Tablet, for suspensionANDA208882-001 · Discontinued
- DEFERASIROX 360MG · GranuleANDA213146-003 · Discontinued
- DEFERASIROX 90MG · GranuleANDA213146-001 · Discontinued
- DEFERASIROX 180MG · GranuleANDA213146-002 · Discontinued
- DEFERASIROX 180MG · GranuleANDA214559-002 · Prescription
- DEFERASIROX 360MG · GranuleANDA214559-003 · Prescription
- DEFERASIROX 90MG · GranuleANDA214559-001 · Prescription
- DEFERASIROX 360MG · TabletANDA211852-002 · Discontinued
- DEFERASIROX 180MG · TabletANDA211852-003 · Discontinued
- DEFERASIROX 90MG · TabletANDA211852-001 · Discontinued
- DEFERASIROX 180MG · TabletANDA212669-002 · Prescription
At a glance
- Brand name
- Deferasirox
- Route
- Oral
- Dosage form
- Tablet
- Applicant
- Teva Pharms USA
- Status
- Discontinued
- FDA approval
- 24 Apr 2020
- Application
- ANDA209223-001